Virtu Financial’s Cellectar Biosciences CLRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-51
| Closed | -$6K | – | 1785 |
|
|
2022
Q2 | $6K | Buy |
+51
| New | +$6K | ﹤0.01% | 1450 |
|
|
2022
Q1 | – | Sell |
-125
| Closed | -$25K | – | 1560 |
|
|
2021
Q4 | $25K | Buy |
+125
| New | +$25K | ﹤0.01% | 1485 |
|
|
2021
Q3 | – | Sell |
-166
| Closed | -$59K | – | 1558 |
|
|
2021
Q2 | $59K | Buy |
+166
| New | +$59K | 0.01% | 1307 |
|
|
2021
Q1 | – | Sell |
-756
| Closed | -$472K | – | 1650 |
|
|
2020
Q4 | $472K | Buy |
+756
| New | +$472K | 0.05% | 457 |
|
|
2018
Q3 | – | Sell |
-32
| Closed | -$59K | – | 1596 |
|
|
2018
Q2 | $59K | Buy |
+32
| New | +$59K | ﹤0.01% | 1726 |
|
|
2018
Q1 | – | Sell |
-13
| Closed | -$55K | – | 2023 |
|
|
2017
Q4 | $55K | Buy |
+13
| New | +$55K | ﹤0.01% | 2062 |
|